Rhenman & Partners Asset Management Ab Portfolio Holdings by Sector
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
Industry | Value | Buys | Sells | New Positions | Closed Positions | Options |
---|---|---|---|---|---|---|
Biotechnology | Healthcare
VRTX REGN BMRN JAZZ INSM ALNY RPRX AXSM 40 stocks |
$218,139
25.97% of portfolio
|
  13  
|
  20  
|
  6  
|
- |
0
Calls
0
Puts
|
Healthcare Plans | Healthcare
UNH ALHC MOH ELV CVS OSCR HUM CI 9 stocks |
$167,912
19.99% of portfolio
|
  3  
|
  6  
|
- | - |
0
Calls
0
Puts
|
Medical Devices | Healthcare
BSX GKOS PRCT MDT PODD DXCM ZBH ABT 12 stocks |
$160,719
19.13% of portfolio
|
  6  
|
  6  
|
  2  
|
- |
0
Calls
0
Puts
|
Drug Manufacturers—General | Healthcare
LLY GILD BMY ABBV BIIB MRK AMGN 7 stocks |
$110,019
13.1% of portfolio
|
  2  
|
  5  
|
  1  
|
- |
0
Calls
0
Puts
|
Diagnostics & Research | Healthcare
NTRA EXAS DHR TMO IQV ICLR MEDP 7 stocks |
$59,780
7.12% of portfolio
|
  2  
|
  5  
|
  1  
|
- |
0
Calls
0
Puts
|
Medical Distribution | Healthcare
MCK ABC 2 stocks |
$37,770
4.5% of portfolio
|
  1  
|
  1  
|
- | - |
0
Calls
0
Puts
|
Medical Care Facilities | Healthcare
THC HCA AMEH EHC 4 stocks |
$32,133
3.83% of portfolio
|
  1  
|
  3  
|
- | - |
0
Calls
0
Puts
|
Medical Instruments & Supplies | Healthcare
ISRG BDX RGEN 3 stocks |
$30,430
3.62% of portfolio
|
- |
  3  
|
- | - |
0
Calls
0
Puts
|
Drug Manufacturers—Specialty & Generic | Healthcare
NBIX DVAX ESPR ALKS 4 stocks |
$20,083
2.39% of portfolio
|
- |
  4  
|
- | - |
0
Calls
0
Puts
|
Health Information Services | Healthcare
PRVA 1 stocks |
$2,204
0.26% of portfolio
|
- |
  1  
|
- | - |
0
Calls
0
Puts
|
Specialty Chemicals | Basic Materials
AVTR 1 stocks |
$775
0.09% of portfolio
|
- |
  1  
|
- | - |
0
Calls
0
Puts
|